Oct 21, 2020
Immutep Activities Report for the First Quarter of Fiscal Year 2021
Oct 18, 2020
Immutep to Present AIPAC Overall Survival Data at the San Antonio Breast Cancer Symposium 2020
Sep 16, 2020
Immutep Announces Improving Results from Stage I of Phase II TACTI-002 Study
Immutep Reports Improving Results from INSIGHT-004 Trial
Aug 30, 2020
Immutep and Monash University Receive Grant Funding for LAG-3 Project
Aug 25, 2020
New Data From Immutep’s Efti To Be Presented At ESMO
Aug 17, 2020
Immutep Completes Recruitment for Stage 1 of Part B in TACTI-002 Study
Immutep Issues Newsletter Update to Shareholders
Aug 11, 2020
Immutep Granted United States Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination
Jul 22, 2020
Immutep Quarterly Activities Report
Jul 13, 2020
Immutep Announces United States Patent Grant for IMP701 Antibody
Jun 28, 2020
Immutep Completes Recruitment for Part A Of Phase II TACTI-002 Study
Jun 21, 2020
Immutep Receives A$1,437,826 R&D Tax Incentive
May 30, 2020
Immutep Announces Improving Data from the Phase II TACTI-002 Study
Immutep Reports First Results from INSIGHT-004 Study
